600566 济川药业
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额880,3401,198,2942,176,4373,463,9592,620,833
投资活动产生之现金流量净额(2,550,915)(976,254)(2,039,917)(394,228)(1,503,306)
筹资活动产生之现金流量净额160,127(1,452,269)(1,205,141)(150,689)(117,582)
汇率变动对现金及现金等价物的影响(10)(10)------
现金及现金等价物净增加/(减少)(1,510,459)(1,230,239)(1,068,620)2,919,042999,945
期初现金及现金等价物余额5,439,1246,669,3637,737,9834,818,9413,818,996
期末现金及现金等价物余额3,928,6655,439,1246,669,3637,737,9834,818,941